Cart
sales@molnova.com
Isoxepac
CAS No. 55453-87-7
Isoxepac( Olopatadine USP Related Compound C | HP 549 )
Catalog No. M27889 CAS No. 55453-87-7
Isoxepac is a non-steroidal anti-antiphlogistic agent and analgesic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 37 | In Stock |
|
| 1G | 52 | In Stock |
|
Biological Information
-
Product NameIsoxepac
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsoxepac is a non-steroidal anti-antiphlogistic agent and analgesic.
-
DescriptionIsoxepac is a non-steroidal anti-antiphlogistic agent and analgesic.
-
In Vitro——
-
In Vivo——
-
SynonymsOlopatadine USP Related Compound C | HP 549
-
PathwayOthers
-
TargetOther Targets
-
RecptorAkt|ERK|JNK|mTOR|NF-κB|p38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55453-87-7
-
Formula Weight268.268
-
Molecular FormulaC16H12O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (372.77 mM)
-
SMILESOC(=O)Cc1ccc2OCc3ccccc3C(=O)c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Beaver C, et al. Vincristine Minibag Administration: A Quality Improvement Project to Minimize Medical Errors. Clin J Oncol Nurs. 2018 Dec 1;22(6):669-672.
molnova catalog
related products
-
2′,2′-Difluorodeoxyu...
2′,2′-Difluorodeoxyuridine (dFdU), the major metabolite of Gemcitabine, exhibits anticancer and antitumor activities, shows radiosensitization under hypoxic conditions, and can be used to study pancreatic cancer.
-
Melrilimab
Melrilimab (GSK 3772847), an IgG2-kappa monoclonal antibody targeting IL1RL1/ST2/IL33R/DER4/FIT-1, is utilized in asthma research .
-
RC-3095
RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.
